Anders Kronborg

This profile gathers the share dealings of Anders Kronborg in SynAct Pharma AB. Between 30 April 2024 and 10 March 2026, the trades on record add up to 7 filings.

No open-market sale appears; the market trades are 5 purchases worth €42k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant. 2026 to date brings 2 purchases and no sales.

Half of the purchases are above €6,639 and half below. On 4 out of 5 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The newest entry dates from 10 March 2026: an open-market purchase of €4,688, in SynAct Pharma AB. The median gap between a trade and its publication by Finansinspektionen is 1 day. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.